myemella

myfemella

Bakterienkulturen und Botanicals

Die neue Generation von Bakterienkulturen,
kombiniert mit Cranberry, Goldrute und Lactoferrin

sporebiotics
  • Zur Vorbeugung von Blasenentzündungen, vor allem wiederkehrende Blasenentzündungen [5 – 8]
  • Verringert das Anhaften (Adhäsion) der Bakterien an die Blasenwand [8, 9]
  • Cranberry verbessert in Kombination mit Bacillus subtilis die Bioverfügbarkeit von Phenolen und fördert die Darmflora [9]
Goldrute
Die echte Goldrute, Solidago virgaurea, war schon im Altertum als Heil¬pflanze bekannt. Seit über 700 Jahren ist die Pflanze als Mittel gegen Harnwegsinfekte bekannt. Echte Goldrute enthält etwa 1,4 Prozent Flavonoide, vor allem die Sub-stanz Rutosid. Bei der Einnahme von Goldrutenextrakt sollte immer darauf geachtet werden, viel zu trinken.

Lactoferrin
Nährstoffgehalt

Zutaten:
Cranberry-Extrakt; Füllstoff: mikrokristalline Cellulose; Lactoferrin [1] (Protein aus Milch); Füllstoff: Dicalciumphosphat; Trennmittel: Speisefett¬säuren; Füllstoff: Gummi arabicum; Überzugsmittel: Hydroxypropylmethyl¬cellulose; Füllstoff: Polydextrose; Farbstoff: Calciumcarbonat; Bacillus coagulans [2], Bacillus subtilis [3]; Füllstoff: Siliciumdioxid; Trennmittel; Magnesiumsalze der Speisefettsäuren; Pulver der Goldrute (Solidago virgaurea L.); pflanzliches Öl (Kokos, Palm); Farbstoff: Eisenoxide und Eisenhydroxide, Indigotin. [1] LFG90 [2] ATCC 7050 [3] LMG P-31319

Nahrungsergänzungsmittel mit Bakterienkulturen, Cranberry, Goldrute und Lactoferrin

Verzehrempfehlung:
Einmal täglich eine Tablette mit einem großen Glas Wasser einnehmen. Nicht bei vorliegender Milcheiweißallergie verwenden. Die empfohlene tägliche Verzehrmenge darf nicht überschritten werden. Nahrungsergänzungsmittel sollten nicht als Ersatz für eine ausgewogene und abwechslungsreiche Ernährung verwendet werden.

myfemella - Auf einen Blick
selenase
Wenn Sie zum pharmazeutischen Personal gehören, loggen Sie sich bitte hier ein oder registrieren Sie sich, um diesen Inhalt sehen zu können.
selenase
Informationen für Verbraucher

Literatur
1. Medina M, et al. Ther Adv Urol. 2019; 11: 1756287219832172. An introduction to the epidemiology and burden of urinary tract infections.
2. Wagenlehner F, et al. Expert Rev Pharmacoecon Outcomes Res. 2018; 18(1): 107-117. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT).
3. Flores-Mireles AL, et al. Nat Rev Microbiol. 2015; 13(5): 269-284. Urinary tract infections: epidemiology, mechanisms of infection and treatment options.
4. Wang CH, et al. Arch Intern Med. 2012; 172(13): 988-996. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials.
5. Liska DJ, et al. Adv Nutr. 2016; 7(3): 498-506. Cranberries and Urinary Tract Infections: How Can the Same Evidence Lead to Conflicting Advice?
6. Rafsanjany N, et al. J Agric Food Chem. 2015; 63(40): 8804-8818. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
7. Ledda A, et al. Eur Rev Med Pharmacol Sci. 2017; 21(2): 389-393. Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections.
8. Singh I, et al. Int Urol Nephrol. 2016; 48(9): 1379- 1386. Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study.
9. Dudonné S, et al. PharmaNutrition 2015; 3(3); 89- 100. Modulatory effects of a cranberry extract cosupplementation with Bacillus subtilis CU1 probiotic on phenolic compounds bioavailability and gut microbiota composition in high-fat diet-fed mice
10. Ofek I, et al. Nature. 1977; 265(5595): 623-625. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.
11. Vahlensieck W, et al. Antibiotics (Basel). 2019; 8(4): 256. Effect of a Herbal Therapy on Clinical Symptoms of Acute Lower Uncomplicated Urinary Tract Infections in Women: Secondary Analysis from a Randomized Controlled Trial.
12. Drago-Serrano ME, et al. Int J Mol Sci. 2017; 18(3): 501. Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.
13. Yen CC, et al. Biometals. 2011; 24(4): 585-594. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
14. Qiu J, et al. Proc Natl Acad Sci U S A. 1998; 95(21): 12641-12646. Human milk lactoferrin inactivates two putative coloni
15. Håversen LA, et al. Infect Immun. 2000; 68(10): 5816-5823. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
16. Patras KA, et al. J Innate Immun. 2019; 11(6): 481- 495. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
17. Hun L. Postgrad Med. 2009; 121(2): 119-124. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
18. Urgesi R, et al. Eur Rev Med Pharmacol Sci. 2014; 18(9): 1344-1353. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
19. Majeed M, et al. Food Nutr Res. 2018; 62:10.29219/ fnr.v62.1218. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
20. Kalman DS, et al. BMC Gastroenterol. 2009; 9: 85. A prospective, randomized, double-blind, placebocontrolled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
21. Nyangale EP, et al. J Nutr. 2015; 145(7): 1446-1452. Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
22. Sudha MR, et al. Int. J. Probiotics Prebiotics 7, 33-37 (2012). Efficacy of Bacillus coagulans strain unique IS-2 in the treatment of patients with acute diarrhea.
23. Maity C, et al. Eur J Clin Pharmacol. 2019; 75(1): 21-31. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
24. Lefevre M, et al. Immun Ageing. 2015; 12: 24. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebocontrolled study.
25. Coppi F, et al. Chemioterapia. 1985; 4(6): 467-470. Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis.
26. Ratna Sudha M, et al. Indian J Microbiol. 2012; 52(3): 396-399. Clinical Study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial Vaginosis.
27. Cao J, et al. Journal of Functional Foods, 2020; 64; 103643. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases.